1,656
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Tailoring thixotropic mixed-lipid nanoconstructs of voriconazole for the management of Vulvovaginal candidiasis: Formulation, statistical optimization, in vitro characterization and in vivo assessment

, &
Pages 1877-1889 | Received 21 Jul 2021, Accepted 23 Aug 2021, Published online: 14 Sep 2021

References

  • Abdel-Salam FS, Mahmoud AA, Ammar HO, Elkheshen SA. (2017). Nanostructured lipid carriers as semisolid topical delivery formulations for diflucortolone valerate. J Liposome Res 27:41–55.
  • Abouelatta SM, Aboelwafa AA, El-Gazayerly ON. (2018). Gastroretentive raft liquid delivery system as a new approach to release extension for carrier-mediated drug. Drug Delivery 25:1161–74.
  • Abuosamra MM, Mohsen AM. (2016). Solid lipid nanoparticles and nanostructured lipid carriers of tolnaftate: design, optimization and in-vitro evaluation. Int J Pharm Pharm Sci 8:380–5.
  • Berkow EL, Lockhart S. (2017). Fluconazole resistance in Candida species: a current perspective. Infect Drug Resist 10:237–45.
  • Bolla PK, Clark BA, Juluri A, et al. (2020). Evaluation of formulation parameters on permeation of ibuprofen from topical formulations using Strat-M® membrane. Pharmaceutics 12:151.
  • Culling CFA. (2013). Handbook of histopathological and histochemical techniques: including museum techniques, Butterworth-Heinemann.
  • Deshkar SS, Palve VK. (2019). Formulation and development of thermosensitive cyclodextrin-based in situ gel of voriconazole for vaginal delivery. J Drug Deliv Sci Technol 49:277–85.
  • Deshmukh K, Amin P. (2013). Formulation and evaluation of solid–lipid nanoparticle based 0.1% Soy isoflavone dermal gels. Pharm BioSci 1:7–18.
  • Duong V-A, Nguyen T-T-L, Maeng H-J, Chi S-C. (2019). Preparation of ondansetron hydrochloride-loaded nanostructured lipid carriers using solvent injection method for enhancement of pharmacokinetic properties. Pharm Res 36:138–12.
  • Duong V-A, Nguyen T-T-L, Maeng H-J. (2020). Preparation of solid lipid nanoparticles and nanostructured lipid carriers for drug delivery and the effects of preparation parameters of solvent injection method. Molecules 25:4781.
  • El-Hammadi MM, JL. Arias (2021). Nanomedicine for vaginal drug delivery. In: Theory and applications of nonparenteral nanomedicines. Amsterdam: Elsevier, 235–57.
  • Faraji R, Rahimi MA, Rezvanmadani F, Hashemi M. (2012). Prevalence of vaginal candidiasis infection in diabetic women. Afri J Microbiol Res 6:2773–8.
  • Fauzee AFB, Walker RB. (2020). The impact of formulation variables on the optimization of pilot scale clobetasol 17-propionate creams. Cogent Eng 7:1804713.
  • Firdaus S, Hassan N, Mirza MA, et al. (2021). FbD directed fabrication and investigation of luliconazole based SLN gel for the amelioration of candidal vulvovaginitis: a 2 T (thermosensitive & transvaginal) approach. Saudi J Biol Sci 28:317–26.
  • Garcês A, Amaral M, Lobo JS, Silva A. (2018). Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: a review. Eur J Pharm Sci 112:159–67.
  • Gollavilli H, Hegde AR, Managuli RS, et al. (2020). Naringin nano-ethosomal novel sunscreen creams: development and performance evaluation. Colloids Surf B Biointerfaces 193:111122.
  • Gonzalez GM, Portillo OJ, Uscanga GI, et al. (2009). Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model. J Antimicrob Chemother 64:571–3.
  • Gonzalez-Mira E, Egea M, Souto E, et al. (2011). Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery. Nanotechnology 22:045101.
  • Gujjar S, Madhavi B, Karki R. (2019). Formulation and evaluation of topical Gel containing nanostructured lipid carriers dispersion of an antifungal drug. actapharm 57:57.
  • Jakubiak P, Thwala LN, Cadete A, et al. (2017). Solvent-free protamine nanocapsules as carriers for mucosal delivery of therapeutics. Eur Polym J 93:695–705.
  • Kenechukwu FC, Attama AA, Ibezim EC, et al. (2018). Novel intravaginal drug delivery system based on molecularly PEGylated lipid matrices for improved antifungal activity of miconazole nitrate. BioMed Res Int 2018:1–18.
  • Liu S, Sun C, Xue Y, Gao Y. (2016). Impact of pH, freeze-thaw and thermal sterilization on physicochemical stability of walnut beverage emulsion. Food Chem 196:475–85.
  • Mendes M, Basso J, Silva J, et al. (2020). Biomimeting ultra-small lipid nanoconstructs for glioblastoma treatment: a computationally guided experimental approach. Int J Pharm 587:119661.
  • Nakamura F, Ohta R, Machida Y, Nagai T. (1996). In vitro and in vivo nasal mucoadhesion of some water-soluble polymers. Int J Pharm 134:173–81.
  • Niculae G, Badea N, Meghea A, et al. (2013). Coencapsulation of butyl-methoxydibenzoylmethane and octocrylene into lipid nanocarriers: UV performance, photostability and in vitro release. Photochem Photobiol 89:1085–94.
  • Pereira I, Zielińska A, Ferreira NR, et al. (2018). Optimization of linalool-loaded solid lipid nanoparticles using experimental factorial design and long-term stability studies with a new centrifugal sedimentation method. Int J Pharm 549:261–70.
  • Pradhan M, Singh D, Murthy SN, Singh MR. (2015). Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis. Steroids 101:56–63.
  • Qin F, Wang Q, Zhang C, et al. (2018). Efficacy of antifungal drugs in the treatment of vulvovaginal candidiasis: a Bayesian network meta-analysis. Infect Drug Resist 11:1893–901.
  • Rehman S, Nabi B, Baboota S, Ali J. (2021). Tailoring lipid nanoconstructs for the oral delivery of paliperidone: formulation, optimization and in vitro evaluation. Chem Phys Lipids 234:105005.
  • Sabo JA, Abdel-Rahman SM. (2000). Voriconazole: a new triazole antifungal. Ann Pharmacother 34:1032–43.
  • Salah S, Awad GE, Makhlouf AI. (2018). Improved vaginal retention and enhanced antifungal activity of miconazole microsponges gel: formulation development and in vivo therapeutic efficacy in rats. Eur J Pharm Sci 114:255–66.
  • Sanad RA, Abdelmalak NS, Elbayoomy TS, Badawi AA. (2010). Formulation of a novel oxybenzone-loaded nanostructured lipid carriers (NLCs). Aaps Pharmscitech 11:1684–94.
  • Sardi J. d C O, Silva DR, Anibal PC, et al. (2021). Vulvovaginal Candidiasis: epidemiology and risk factors, pathogenesis, resistance, and new therapeutic options. Curr Fungal Infect Rep 15:1–9.
  • Sawant B, Khan T. (2017). Recent advances in delivery of antifungal agents for therapeutic management of candidiasis. Biomed Pharmacother 96:1478–90.
  • Sek L, Porter CJ, Kaukonen AM, Charman WN. (2002). Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products. J Pharm Pharmacol 54:29–41.
  • Thompson GR, III, Lewis JS. (2010). Pharmacology and clinical use of voriconazole. Expert Opin Drug Metab Toxicol 6:83–94.
  • Waghule T, Rapalli VK, Singhvi G, et al. (2019). Voriconazole loaded nanostructured lipid carriers based topical delivery system: QbD based designing, characterization, in-vitro and ex-vivo evaluation. J Drug Delivery Sci Technol 52:303–15.
  • Wang K, Zhang Q-j, Miao Y-L, et al. (2017). Effect of solid lipid;s structure on nanostructured lipid carriers encapsulated with sun filter: characterisation, photo-stability and in vitro release. J Microencapsul 34:104–10.
  • Youssef A, Dudhipala N, Majumdar S. (2020). Ciprofloxacin loaded nanostructured lipid carriers incorporated into in-situ gels to improve management of bacterial endophthalmitis. Pharmaceutics 12:572.
  • Yu Q, Hu X, Ma Y, et al. (2016). Lipids-based nanostructured lipid carriers (NLCs) for improved oral bioavailability of sirolimus. Drug Deliv 23:1469–75.
  • Zheng M, Falkeborg M, Zheng Y, et al. (2013). Formulation and characterization of nanostructured lipid carriers containing a mixed lipids core. Colloids Surf A 430:76–84.